Masaru Matsuda - May 31, 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Reporting Person's title: Senior Vice President General Counsel and Corporate Secretary
Signature: /s/ David Topper, as Attorney-in-Fact for Masaru Matsuda
Stock symbol: ARQT
Transactions as of: May 31, 2024
Transactions value $: $18,543
Form type: 4
Date filed: 12/3/2024, 04:16 PM
Previous filing: May 29, 2024
Next filing: Aug 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Purchase	$6.77K	+4K	+2.21%	$1.69	185K	May 31, 2024	Direct	F1
transaction	ARQT	Common Stock	Purchase	$11.8K	+1.66K	+0.89%	$7.11	187K	Nov 30, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the purchase transaction of the Company's Employee Stock Purchase Plan.

Remarks:

Reporting Person's title: Senior Vice President General Counsel and Corporate Secretary